识别了多ADP-ribose) 聚合酶9 (PARP9) 作为一种强大的抑制剂,用于Mycobacterium tuberculosis感染

Zhenyu Zhu1, Shufeng Weng1, Fen Zheng1

  • 1State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, 200433 China.

PubMed
概括

在结核病患者中,多分子ADP-ribose聚合酶 (PARP) 发生变化. PARP9作为对抗Mycobacterium感染的抑制剂,减少了细菌的增殖.